SAN DIEGO, June 02, 2025 -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the...
Art Pappas will participate on a panel to discuss exit strategies, the growing role of Pharma venture capital and alternative financing strategies at the 8th annual BioExec Institute Retreat on Friday, March 23 in Miami, Florida.
News | 03. 19. 2012
Art Pappas will participate on a panel to discuss exit strategies, the growing role of Pharma venture capital and alternative financing strategies at the 8th annual BioExec Institute Retreat on Friday, March 23 in Miami, Florida.
